HNF4A Defines Molecular Subtypes and Vulnerability to Transforming Growth Factor β-Pathway Targeted Therapies in Cancers of the Distal Esophagus

Gastroenterology. 2022 Nov;163(5):1457-1460. doi: 10.1053/j.gastro.2022.07.073. Epub 2022 Aug 4.
No abstract available

Publication types

  • Research Support, Non-U.S. Gov't
  • Research Support, N.I.H., Extramural

MeSH terms

  • Esophagus / metabolism
  • Hepatocyte Nuclear Factor 4
  • Humans
  • Neoplasms* / metabolism
  • Transforming Growth Factor beta* / metabolism

Substances

  • Transforming Growth Factor beta
  • HNF4A protein, human
  • Hepatocyte Nuclear Factor 4